Yeji
FDA approvalconf 0.99

auvelity — FDA approval

$AXSM · Axsome Therapeutics, Inc.
Event date
August 19, 2022
1387 days ago
Sponsor runway
44 mo
$305.1M liquid

Evidence

“the U.S. Food and Drug Administration (FDA) has approved AUVELITY TM for the treatment of major depressive disorder (MDD) in adults.”
Source: 8-K filed 2022-08-19View on EDGAR ↗0001193125-22-224610

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)
TickerDrugDateOutcome
$INCYzynyz2026-05-18success
$INCYjakafi xr2026-05-01success
$AXSMauvelity2026-04-30success
$INCYzynyz2026-03-30success
$BIIBspinraza2026-03-27success
$CORTlifyorli2026-03-25success
$RYTMimcivree2026-03-19success
$ASNDyuviwel2026-02-27success
$BMRNpalynziq2026-02-27success
$ETONdesmoda2026-02-25success

Recent insider activity· ±90 days

3 insiders · 0 buys · 0 sells
Grant
2022-06-03
JEFFS ROGER
Director
16,976 @ ——
Grant
2022-06-03
Coleman Mark
Director
16,976 @ ——
Grant
2022-06-03
Saad Mark E
Director
16,976 @ ——
← All catalysts for $AXSM